DCH Nerve Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
DCH Nerve Pain Relief
Generic name
LIDOCAINE 4%, MENTHOL 1%
Manufacturer
Derma Care Research Labs, LLC
Product type
HUMAN OTC DRUG
SPL set ID
00db480a-e510-a64d-e063-6394a90a4695
SPL ID
29a5b163-b687-0ea4-e063-6394a90a850c
Version
2
Effective date
2024-12-19
Source export date
2026-09-28
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:53:46
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. Flammable-- Keep away from fire or flame. Do not use if you have had an allergic reaction to lidocaine or other local anesthetics, on large areas of he body or on cut, irritated, blistered or swollen skin, on puncture wounds, for more than one week without consulting a doctor. When using this product only use as directed, avoid contact with eyes and mucous membranes, rare cases of serious burns have been reported with products of this type, do not apply to wounds or damaged, broken, or irritated skin, do not bandage tightly or apply local heat (such as heating pads) or a medicated path to the area of use, a transient burning sensation may occur upon application but generally disappears in several days, avoid applying into skin folds. Stop use and ask a doctor if condition worsens, severe burning sensation, redness, rash or irritation develops, symptoms persist for more than 7 days or clear up and occur again within a few days, you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied. .

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.